{"id":244254,"date":"2012-03-22T17:58:35","date_gmt":"2012-03-22T17:58:35","guid":{"rendered":"http:\/\/www.eugenesis.com\/schiff-nutrition-international-inc-announces-fiscal-2012-third-quarter-results\/"},"modified":"2012-03-22T17:58:35","modified_gmt":"2012-03-22T17:58:35","slug":"schiff-nutrition-international-inc-announces-fiscal-2012-third-quarter-results","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/schiff-nutrition-international-inc-announces-fiscal-2012-third-quarter-results.php","title":{"rendered":"Schiff Nutrition International, Inc. Announces Fiscal 2012 Third Quarter Results"},"content":{"rendered":"<p><p>    SALT LAKE CITY--(BUSINESS WIRE)--  <\/p>\n<p>    Schiff Nutrition International, Inc., (NYSE:WNI    -     News), announced results for the three- and nine-month    periods ended February 29, 2012.  <\/p>\n<p>    We are pleased with our third quarter performance, stated    Tarang Amin, president and chief executive officer. Net sales    grew 25%, which was driven by a 53% increase in our branded    business. These results reflect successful execution against    Schiffs growth strategy as we invest to build premium brands    and lead innovation in our categories. Our core brands Schiff    Move Free and Schiff MegaRed, in    particular, benefited from strong marketing and sales execution    as well as traction from new items.  <\/p>\n<p>    Three Months Results Ended February 29, 2012  <\/p>\n<p>    For the fiscal 2012 third quarter ended February 29, 2012, net    sales were $72.2 million, compared to $57.7 million for the    same period in fiscal 2011. The 25% increase reflects growth in    key brands, new product introductions and a full quarters    contribution from the probiotics acquisition. Branded sales    results were partially offset by an expected decline in private    label business. Selling and marketing expenses were $17.8    million, or 25% of revenue, compared to $7.9 million, or 14% of    revenue. Net income for the fiscal 2012 third quarter was $4.6    million, compared to net income of $4.0 million for the same    period in fiscal 2011. Earnings per diluted share were $0.16    for the fiscal 2012 third quarter, compared to $0.14 for the    same period in fiscal 2011. Adjusted EBITDA, which is defined    as income from operations before depreciation, amortization and    stock-based compensation, was $9.3 million for the fiscal 2012    third quarter, compared to $7.4 million for the same period in    fiscal 2011.  <\/p>\n<p>    Nine Months Results Ended February 29, 2012  <\/p>\n<p>    For the first nine months of fiscal 2012, net sales were $191.5    million, compared to $161.8 million for the same period in    fiscal 2011. Selling and marketing expenses were $45.0 million,    or 24% of revenue, compared to $26.2 million, or 16% of    revenue. Net income for the first nine months of fiscal 2012    was $11.8 million, compared to net income of $9.6 million for    the same period in fiscal 2011. Earnings per diluted share were    $0.40 for the first nine months of fiscal 2012, compared to    $0.33 for the same period in fiscal 2011. Adjusted EBITDA was    $25.3 million for the first nine months of fiscal 2012,    compared to $21.5 million for the same period in fiscal 2011.  <\/p>\n<p>    We are positioning Schiff for long-term growth. Our sales and    gross margins continue to benefit from our investments in brand    building. It is gratifying the business has responded to these    efforts so positively in fiscal 2012, concluded Amin.  <\/p>\n<p>    Company Outlook  <\/p>\n<p>    The company adjusted its fiscal year 2012 expectations. Net    sales are expected to grow 16% to 19% as compared to fiscal    year 2011 net sales of $213.6 million. Gross profit percentage    is expected to be in the range of 44% to 46%. Selling and    marketing expenses, as a percentage of net sales, are estimated    to be in the range of 23.0% to 24.5%. Other operating expenses    are estimated at approximately $27.5 million to $29.0 million.    The company continues to anticipate a very high single-digit    operating margin for fiscal 2012.  <\/p>\n<\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/schiff-nutrition-international-inc-announces-110500857.html\" title=\"Schiff Nutrition International, Inc. Announces Fiscal 2012 Third Quarter Results\">Schiff Nutrition International, Inc. Announces Fiscal 2012 Third Quarter Results<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SALT LAKE CITY--(BUSINESS WIRE)-- Schiff Nutrition International, Inc., (NYSE:WNI - News), announced results for the three- and nine-month periods ended February 29, 2012.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/schiff-nutrition-international-inc-announces-fiscal-2012-third-quarter-results.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577479],"tags":[],"class_list":["post-244254","post","type-post","status-publish","format-standard","hentry","category-nutrition"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244254"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=244254"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244254\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=244254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=244254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=244254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}